by admin | Nov 25, 2019 | Funding
Azeria Therapeutics, a newly formed pioneer factor drug discovery company, announced a £32 million Series B financing in which Syncona has committed £29.5 million alongside existing investor the CRT Pioneer Fund. Azeria was originally founded in 2017 by Sixth Element...
by admin | Nov 25, 2019 | CE mark
AiVoni Analysis Service by Heart2Save from Finland determines four different arrhythmias, allowing especially detection of atrial fibrillation. Early detection of arrhythmia significantly reduces the number of strokes caused by atrial fibrillation and thus saves lives...
by admin | Nov 25, 2019 | M&A - Buy-Out
Alkermes and Rodin Therapeutics announced that they have entered into a definitive agreement under which Alkermes will acquire Rodin, a privately held biopharmaceutical company focused on developing novel, small molecule therapeutics for synaptopathies. This...
